Latest News by Industry
MODI`IN, Israel (AP) _ Vascular Biogenics Ltd. (VBLT) on Monday reported a loss of $9.2 million in its third quarter.
On a per-share basis, the Modi`In, Israel-based company said it had a loss of 12 cents.
The gene therapy biotech company posted revenue of $481,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a VBLT">Zacks stock report on VBLT at https://www.zacks.com/ap/VBLT